📰 Analgesic Program News
Analgesic Program News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Analgesic Program. Real-time updates on events, politics, business and more.
August 31, 2023
Download as PDF Vancouver, British Columbia: PreveCeutical Medical Inc. , announces that it has entered into a Service Agreement dated effective September 1, 2023 with New to the Street...
August 31, 2023
VANCOUVER, BC, Aug. 31, 2023 /PRNewswire/ - PreveCeutical Medical Inc. , announces that it has entered into a Service Agreement dated effective September 1, 2023 with New to the Street Group...
August 31, 2023
VANCOUVER, BC, Aug. 31, 2023 /CNW/ - PreveCeutical Medical Inc. (the "Company" or "PreveCeutical") (CSE:PREV) (OTCQB:PRVCF) (FSE: 18H), announces that it has entered into a Service Agreement dated
July 24, 2023
Download as PDF PreveCeutical Files Cyclic Peptides And Uses Thereof in the EU and Australia Vancouver, British Columbia: PreveCeutical Medical Inc. , is pleased to...
July 24, 2023
/PRNewswire/ - PreveCeutical Medical Inc. (the "Company" or "PreveCeutical") (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H), is pleased to announce that PreveCeutical...
June 28, 2023
Download as PDF PreveCeutical Files Two Family Patents of Sol-Gel Cannabinoid Formulation And Antiviral Use & Cyclic Peptides And Uses Thereof Vancouver, British Columbia: PreveCeutical Medical Inc. (the "Company" ...
May 30, 2023
Download as PDF PreveCeutical Medical - Sol-Gel and Uses thereof Patent Update Vancouver, British Columbia: PreveCeutical Medical Inc. , is pleased to announce that... | May 30, 2023
April 24, 2023
Download as PDF PreveCeutical Medical Launches Clinical Artificial Intelligence Division Vancouver, British Columbia: PreveCeutical Medical Inc. , is pleased to announce... | June 18, 2023
April 4, 2023
Download as PDF PreveCeutical Medical Announces Frontiers Media SA Publication Featuring Data from its Analgesic Program for the Treatment of Peptide-based Therapeutics for Moderate to... | April 4, 2023
March 6, 2023
Vancouver, British Columbia--(Newsfile Corp. - March 6, 2023) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company" or "PreveCeutical"), is pleased to announce that PreveCeutical